| Released | Contributor | Author | Title | Pages | Price |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| TRMS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards. | 58 |
$20 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for TRMS | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: TRIMERIS INC | 5 |
$25 |
| 21-Nov-2009 | Standard & Poor's STARS Report |
N/A
| Trimeris Inc | 6 |
$35 |
| 20-Nov-2009 | Pechala's Reports | Lubomir Pechala | TRIMERIS INC (TRMS=US) 2-weeks forecast | 1 |
$10 |
| 20-Nov-2009 | Pechala's Reports | Frantisek Pechala | TRIMERIS INC (TRMS=US) 12-months forecast | 1 |
$15 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: TRIMERIS -- TRMS | 1 |
$4 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , TRMS , XNPT -- DRUGS | 3 |
$4 |
1.48% Nasdaq 
0.03 (0.91%) 
Research Reports
